- Global Pharma News & Resources

Cardiac Arrhythmia Monitoring Devices Market to Gain Massive Profits During Projected Timespan

Zion Market Research has published a new report titled “Cardiac Arrhythmia Monitoring Devices Market by Device (Event Recorder, Electrocardiogram Monitor, Holter Monitor, Implantable Cardiac Monitor, and Mobile Cardiac Telemetry), End User (Premature Contraction, Bradycardia, and Tachycardia), and End User (Diagnostic Centers, Hospitals and Clinics, Homecare Settings, and ASCs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025” According to the report, global demand for cardiac arrhythmia monitoring devices market was valued at approximately USD 5,349.0 Million in 2018, and is expected to generate revenue of around USD 8,153.6 Million by end of 2025, growing at a CAGR of around 6.3% between 2019 and 2025.

Cardiac Arrhythmia can be described as a collection of conditions in which the heart beat is irregular. Cardiac Arrhythmia or irregular heartbeat can be divided as bradycardia (slow heartbeat), tachycardia (fast heartbeat), premature contraction (early heartbeat), and fibrillation (irregular heartbeat). Multiple factors can lead to arrhythmia like diabetes, alcohol abuse, heart disorders, and hypertension among other things. Cardiac monitoring is carried out to identify heart rhythm diseases.

Factors such as technological advancements in cardiac arrhythmia monitoring devices, increasing incidence of cardiovascular disorders, growing preference for low cost ECG devices, and healthcare cost containment will act as major driving factors in the growth of global cardiac arrhythmia monitoring devices market. Favorable government policies worldwide, increasing healthcare spending in developing regions will act as an opportunity for the market players in the cardiac arrhythmia monitoring devices market. Nonetheless, product recalls, high cost, and lack of awareness in low income countries will restrict the growth of global cardiac arrhythmia monitoring devices market.

The global cardiac arrhythmia monitoring devices market has been split into device, application, and end user. Based on device, cardiac arrhythmia monitoring devices market has been segmented into event recorder, electrocardiogram monitor, Holter monitor, implantable cardiac monitor, and mobile cardiac telemetry. The Holter monitor segment accounted for the highest market share in 2018 due to increasing adoption of such monitors amongst aging people. The application segment has been segmented into premature contraction, bradycardia, and tachycardia. The tachycardia segment accounted for the highest market share in 2018 due to rise in the occurrence of heart ailments such as flutter and atrial fibrillation. The end user segment has been segmented into diagnostic centers, hospitals and clinics, homecare settings, and ASCs.

Get Free Sample of this Report

Regionally, the cardiac arrhythmia monitoring devices market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. Presence of prominent market players, FDA approvals, and rapid acceptance of new technologies will boost the market growth in this region. Europe will be the second largest market. The major reasons are rise in awareness regarding use of cardiac monitoring devices, high prevalence of cardiovascular disorders, and favorable reimbursement scenario. Asia Pacific will propagate at speedy rate over the forecast period due to fast technological updation in the healthcare division and growing cases of cardiovascular disorders. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

The report also includes detailed profiles of key players such as Aurora Resurgence, GE Healthcare, Applied Cardiac Systems, Biotronik, AliveCor, Biotricity, BioTelemetry, Koninklijke Philips N.V., iRhythm Technologies, St. Jude Medical (Abbott Laboratories), Medtronic plc, Spacelabs Healthcare, and Nihon Kohden Corporation among others.

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 28-Aug-2020